Hope, despair and CRISPR — the race to save one woman’s life Researchers in India fought to develop what could have been the first therapy to use gene-editing to halt a rare neurodegenerative disease. The efforts hold lessons for the messy state of modern drug development. By Heidi Ledford
No hay comentarios:
Publicar un comentario